Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.38%3.85B | -12.87%2.56B | -8.22%1.04B | -7.14%5.47B | -3.24%4.3B | 0.56%2.94B | -15.60%1.13B | 12.84%5.9B | 10.65%4.44B | 17.66%2.92B |
| Refunds of taxes and levies | -58.08%42.05M | -52.14%31.1M | 68.72%23.32M | 84.78%115.46M | 97.40%100.32M | 103.64%64.99M | 101.72%13.82M | -58.11%62.49M | -65.55%50.82M | -65.41%31.91M |
| Net deposit increase | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash received relating to other operating activities | -27.12%182.82M | -29.91%109.88M | -0.76%107.24M | 53.50%809.17M | -28.50%250.85M | 3.49%156.77M | -3.28%108.06M | 3.21%527.13M | 11.81%350.86M | -22.37%151.49M |
| Cash inflows from operating activities | -12.31%4.08B | -14.52%2.7B | -6.72%1.17B | -1.32%6.4B | -4.02%4.65B | 1.76%3.16B | -14.11%1.25B | 10.21%6.48B | 8.22%4.84B | 12.07%3.1B |
| Goods services cash paid | -19.49%2.77B | -23.07%1.87B | -22.60%933.85M | -2.31%4.41B | -9.99%3.44B | -3.41%2.43B | 0.20%1.21B | 3.27%4.51B | 3.89%3.82B | 2.72%2.51B |
| Staff behalf paid | 0.31%496.45M | 0.94%358.32M | 6.53%214.8M | 0.19%633.45M | -4.51%494.91M | -5.30%354.99M | -5.62%201.63M | -18.01%632.26M | -16.04%518.29M | -19.84%374.87M |
| All taxes paid | -19.98%170.38M | -21.82%121.6M | -5.98%67.96M | -11.70%253.71M | -12.30%212.91M | 5.43%155.53M | 22.20%72.28M | 0.86%287.34M | -6.81%242.78M | -4.21%147.52M |
| Net loan and advance increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Net lend capital | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash paid relating to other operating activities | -16.40%293.55M | -11.26%174.13M | -6.24%126.97M | -28.10%535.94M | -25.90%351.13M | -8.41%196.24M | -1.02%135.43M | 31.42%745.36M | 9.29%473.87M | -12.19%214.25M |
| Cash outflows from operating activities | -17.09%3.73B | -19.55%2.52B | -16.85%1.34B | -5.60%5.83B | -11.03%4.5B | -3.56%3.14B | 0.13%1.62B | 3.08%6.18B | 1.33%5.06B | -1.88%3.25B |
| Net cash flows from operating activities | 129.75%347.61M | 700.49%176.52M | 51.75%-175.3M | 84.59%568.14M | 171.47%151.3M | 114.89%22.05M | -133.64%-363.32M | 384.01%307.78M | 58.74%-211.71M | 72.81%-148.13M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -56.61%110.24M | -72.35%70.24M | --0 | 276.25%501.03M | 267.00%254.04M | 267.00%254.04M | 1,780.29%193.48M | -60.59%133.16M | -68.99%69.22M | -59.50%69.22M |
| Cash received from returns on investments | 143.17%17.29M | 2,163.58%12.6M | --0 | 346.81%12.15M | -86.37%7.11M | -98.87%556.64K | ---- | -58.78%2.72M | 354.72%52.15M | 559.11%49.43M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 57,793.57%171.93M | 61,274.97%165.33M | 357.71%325.43K | -97.55%1.78M | -98.77%296.97K | -97.70%269.39K | -37.63%71.1K | -0.99%72.73M | 2,239.12%24.09M | 2,000.91%11.7M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --2.75M | --1.37M | ---- |
| Cash received relating to other investing activities | 42,460,733.39%425.03M | 42,460,733.39%425.03M | 21,888.64%323.23M | --0 | -100.00%1K | -100.00%1K | -92.79%1.47M | -70.40%9.32M | -48.93%21M | -71.91%20.4M |
| Cash inflows from investing activities | 177.11%724.48M | 164.15%673.21M | 65.91%323.56M | 133.34%514.95M | 55.78%261.44M | 69.07%254.86M | 145.40%195.02M | -50.89%220.68M | -39.37%167.83M | -40.08%150.75M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -27.46%107.65M | -33.44%75.42M | -49.47%41.2M | -50.19%210.48M | -60.54%148.41M | -61.98%113.3M | -47.85%81.52M | -25.41%422.56M | 16.53%376.12M | 35.87%298.03M |
| Cash paid to acquire investments | 2,403.23%181M | ---- | --0 | --0 | -95.46%7.23M | -95.43%7.23M | ---- | -56.07%156.8M | -52.51%159.13M | 344.00%158.15M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Impawned loan net increase | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash paid relating to other investing activities | 8,644.25%874.43M | --789.4M | --100M | --470M | -50.00%10M | ---- | --0 | --0 | 0.00%20M | --20M |
| Cash outflows from investing activities | 602.18%1.16B | 617.48%864.81M | 73.20%141.2M | 17.45%680.48M | -70.17%165.64M | -74.69%120.53M | -73.79%81.52M | -48.65%579.37M | -30.60%555.24M | 40.78%476.18M |
| Net cash flows from investing activities | -557.81%-438.59M | -242.64%-191.61M | 60.67%182.36M | 53.85%-165.52M | 124.73%95.8M | 141.28%134.33M | 149.01%113.5M | 47.16%-358.68M | 25.96%-387.41M | -275.57%-325.44M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --400K | --400K | --0 | -89.77%19M | ---- | ---- | ---- | 8,155.90%185.76M | 36.55%9.9M | 340.00%9.9M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --400K | --400K | --0 | 91.92%19M | ---- | ---- | ---- | 340.00%9.9M | 36.55%9.9M | 340.00%9.9M |
| Cash from borrowing | -86.34%33.7M | -87.05%31.7M | -84.36%20.7M | -77.70%250.37M | -77.79%246.72M | -77.64%244.72M | -80.45%132.32M | -1.76%1.12B | 20.31%1.11B | 27.37%1.09B |
| Cash received relating to other financing activities | ---- | ---- | --0 | 104.99%104.16M | -97.64%4.16M | ---- | ---- | 15.30%50.81M | --175.86M | --175.86M |
| Cash inflows from financing activities | -86.41%34.1M | -86.88%32.1M | -84.36%20.7M | -72.52%373.52M | -80.65%250.87M | -80.89%244.72M | -80.73%132.32M | 14.31%1.36B | 39.33%1.3B | 48.59%1.28B |
| Borrowing repayment | -94.18%58.82M | -93.08%55.35M | -76.14%50.14M | 17.63%1.27B | 17.45%1.01B | -5.89%800.24M | -61.09%210.13M | 251.44%1.08B | 126.40%860.23M | 172.72%850.3M |
| Dividend interest payment | 66.34%242.73M | 83.98%239.4M | 77.15%21.22M | -5.81%161.76M | -4.69%145.92M | 29.67%130.13M | -7.33%11.98M | -27.63%171.74M | -25.29%153.11M | -48.12%100.36M |
| -Including:Cash payments for dividends or profit to minority shareholders | 104.62%87.78M | 153.00%86.83M | --18.4M | 8.33%42.9M | 8.33%42.9M | 8.33%34.32M | ---- | -1.38%39.6M | 50.00%39.6M | 20.00%31.68M |
| Cash payments relating to other financing activities | 2,310.92%143.06M | 3,823.85%140.26M | 48,418.19%121.14M | 22.10%33.44M | 81.77%5.93M | 471.65%3.57M | -22.59%249.68K | -45.79%27.38M | -86.79%3.26M | -97.02%625.29K |
| Cash outflows from financing activities | -61.75%444.61M | -53.42%435.01M | -13.43%192.49M | 14.58%1.46B | 14.32%1.16B | -1.82%933.94M | -59.81%222.36M | 114.86%1.28B | 66.76%1.02B | 80.77%951.28M |
| Net cash flows from financing activities | 54.96%-410.51M | 41.54%-402.91M | -90.80%-171.79M | -1,441.13%-1.09B | -425.31%-911.36M | -309.49%-689.22M | -167.48%-90.04M | -86.32%81.34M | -12.75%280.15M | -1.90%329M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 20.21%-1.49M | -43.16%537.09K | 1,419.92%1.05M | 278.61%6.43M | -129.44%-1.87M | -88.15%944.92K | 97.20%-79.35K | -87.74%1.7M | -60.73%6.35M | 7.96%7.97M |
| Net increase in cash and cash equivalents | 24.49%-502.98M | 21.51%-417.46M | 51.85%-163.68M | -2,221.32%-681.78M | -113.07%-666.12M | -289.41%-531.9M | -32.52%-339.93M | 117.97%32.14M | 55.29%-312.62M | 52.67%-136.59M |
| Add:Begin period cash and cash equivalents | -19.35%2.84B | -19.35%2.84B | -20.44%2.84B | 0.92%3.52B | 0.86%3.52B | 0.86%3.52B | 2.25%3.57B | -4.87%3.49B | -4.82%3.49B | -4.82%3.49B |
| End period cash equivalent | -18.15%2.34B | -18.97%2.42B | -17.14%2.68B | -19.35%2.84B | -10.17%2.86B | -10.88%2.99B | -0.15%3.23B | 0.92%3.52B | 7.06%3.18B | -0.74%3.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.